CytomX Therapeutics, Inc 10-K for FY2022
CytomX Therapeutics, Inc. (CTMX)
10-K
2023-03-27
For: 2022-12-31
View Original
Added on
April 09, 2026
About this 10-K
CytomX Therapeutics, Inc filed this 10-K on March 27, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $53.16M
- up 42.5% from $37.31M a year earlier
- Net loss
- $99.32M
- compared with a net loss of $115.87M a year earlier